Literature DB >> 22551301

It is our destiny to die: the effects of mortality salience and culture-priming on fatalism and karma belief.

Chih-Long Yen1.   

Abstract

The current study explores whether Asians use culture-specific belief systems to defend against their death anxiety. The effects of mortality salience (MS) and cultural priming on Taiwanese beliefs in fatalism and karma were investigated. Study 1 showed that people believe in fatalism and karma more following MS compared with the control condition. Study 2 found that the effect of MS on fatalism belief was stronger when Taiwanese were exposed to an Eastern cultural context than to a Western cultural context. However, a matched sample of Western participants did not show increased fatalism belief after either a West- or East-prime task. The present research provides evidence that Asians may use some culture-specific beliefs, particularly fatalism belief, to cope with their death awareness.

Entities:  

Mesh:

Year:  2012        PMID: 22551301     DOI: 10.1080/00207594.2012.678363

Source DB:  PubMed          Journal:  Int J Psychol        ISSN: 0020-7594


  3 in total

1.  Health Communication through Positive and Solidarity Messages Amid the COVID-19 Pandemic: Automated Content Analysis of Facebook Uses.

Authors:  Angela Chang; Xuechang Xian; Matthew Tingchi Liu; Xinshu Zhao
Journal:  Int J Environ Res Public Health       Date:  2022-05-19       Impact factor: 4.614

2.  Attributing variance in supportive care needs during cancer: culture-service, and individual differences, before clinical factors.

Authors:  Richard Fielding; Wendy Wing Tak Lam; Shiow Ching Shun; Toru Okuyama; Yeur Hur Lai; Makoto Wada; Tatsuo Akechi; Wylie Wai Yee Li
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

3.  Objective and Subjective Dementia Caregiving Burden: The Moderating Role of Immanent Justice Reasoning and Social Support.

Authors:  Yanchun Cao; Fan Yang
Journal:  Int J Environ Res Public Health       Date:  2020-01-10       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.